β-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs

Diabetes

Volumn 49, Issue 2, 2000, Pages 253-262

  Rashid, Shirya ^a   Shi, Zhi Qing ^a   Niwa, Masataka ^a   Mathoo, Julian M R ^a   Vandelangeryt, MayLiza ^a   Bilinski, Debra ^a   Lewis, Gary F ^a   Vranic, Mladen ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; CARBACHOL; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DIABETES MELLITUS; DOG; GLUCONEOGENESIS; GLUCOSE METABOLISM; HYPERGLYCEMIA; HYPERINSULINEMIA; MALE; METABOLIC CLEARANCE RATE; NONHUMAN; PRIORITY JOURNAL; STRESS;

EID: 0342545893     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.2.253     Document Type: Article

References (56)

1. Pomposelli JJ, Baxter JK, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR: Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 22:77-81, 1998
2. Malchoff CD, Pohl SL, Kaiser DL, Carey RM: Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients. Am J Med 77:275-285, 1984
3. Wasserman DH, Lickley HL, Vranic M: Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs. J Clin Invest 74:1404-1413, 1984
4. el-Tayeb KM, Brubaker PL, Vranic M, Lickley HL: Beta-endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogs. Diabetes 34:1293-1300, 1985
5. Frizzell RT, Jones EM, Davis SN, Biggers DW, Myers SR, Connolly CC, Neal DW, Jaspan JB, Cherrington AD: Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes 42:1253-1261, 1993
6. McGuinness OP, Burgin K, Moran C, Bracy D, Cherrington AD: Role of glucagon in the metabolic response to stress hormone infusion in the conscious dog. Am J Physiol 266:E438-E447, 1994
7. Rizza R, Haymond M, Cryer P, Gerich J: Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol 237:E356-E362, 1979
8. Goldstein RE, Abumrad NN, Lacy DB, Wasserman DH, Cherrington AD: Effects of on acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency. Diabetes 44:672-681, 1995
9. Miles PD, Yamatani K, Lickley HL, Vranic M: Mechanism of glucoregulatory responses to stress and their deficiency in diabetes. Proc Natl Acad Sci U S A 88:1296-1300, 1991
10. Miles PD, Yamatani K, Brown MR, Lickley HL, Vranic M: Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs. Metabolism 43:1134-1143, 1994
11. Mizock BA: Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 98:75-84, 1995
12. Attvall S, Eriksson VM, Fowelin J, von Schenck H, Lager I, Smith U: Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation. J Clin Invest 80:437-442, 1987
13. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997 (Erratum published in Diabetes 46:536, 1997)
14. Boden G, Chen X, Ruiz J, Heifets M, Morris M, Badosa F: Insulin receptor down-regulation and impaired antilipolytic action of insulin in diabetic patients after pancreas/kidney transplantation. J Clin Endocrinol Metab 78:657-663, 1994
15. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
16. Boden G, Jadali F: Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40:686-692, 1991
17. Fisher SJ, Lekas M, Shi ZQ, Bilinski D, Carvalho G, Giacca A, Vranic M: Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes 46:1805-1812, 1997
18. Radziuk J, Norwich KH, Vranic M: Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol 234:E84-E93, 1978
19. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
20. Bradley DC, Steil GM, Bergman RN: Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing. Am J Physiol 264:E902-E911, 1993
21. Bjorkman O, Miles PD, Wasserman D, Lickley HL, Vranic M: Regulation of glucose turnover during exercise in pancreatectomized, totally insulin deficent dogs: effects of beta-adrenergic blockade. J Clin Invest 81:1759-1767, 1988
22. Miles JJ, Glasscock J, Aikens J, Gerich J, Haymond M: A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24:96-99, 1983
23. Lloyd B, Burrin J, Smythe P, Alberti KG: Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 24:1724-1729, 1978
24. Fisher SJ, Shi ZQ, Lickley HLA, Efendic S, Vranic M, Giacca A: A moderate decline in specific activity does not lead to an underestimation of hepatic glucose production during a glucose clamp. Metabolism 45:587-593, 1996
25. Cryer PE, Rizza R, Haymond M, Gerich J: Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism 1114-1118, 1980
26. Lekas M, Fisher SJ, Van Delangerit M, Vranic M, Shi ZQ: Glucose uptake during stress is enhanced by beta-blockade and is not mediated by insulin. J Appl Physiol 87:722-731, 1999
27. Hagstrom-Toft E, Arner P, Johansson U, Eriksson LS, Ungerstedt U, Bolinder J: Effect of insulin on human adipose tissue metabolism in situ: interactions with beta-adrenoceptors. Diabetologia 35:664-670, 1992
28. Chiasson JL, Shikama H, Chu DT, Exton JH: Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest 68:706-713, 1981
29. Pessin JE, Gitomer W, Oka Y, Oppenheimer CL, Czech MP: Beta-adrenergic regulation of insulin and epidermal growth factor receptors in rat adipocytes. J Biol Chem 258:7386-7394, 1983
30. Lonnroth P, Wesslau C, Stenstrom G, Tisell LE, Smith U: Reduced insulin binding to human fat cells following beta-adrenergic stimulation-experimental evidence and studies in patients with pheochromocytoma. Diabetologia 28: 901-906, 1985
31. Bonen A, Megeney LA, McCarthy SC, McDermott JC, Tan MH: Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 187:685-691, 1992
32. Nishimura H, Saltis J, Habberfield AD, Garty NB, Greenberg AS, Cushman SW, Londos C, Simpson IA: Phosphorylation state of the GLUT4 isoform of the glucose transporter in subfractions of the rat adipose cell: effects of insulin, adenosine, and isoproterenol. Proc Natl Acad Sci U S A 88:11500-11504, 1991
33. Joost H, Weber M, Cushman S, Simpson I: Insulin stimulated glucose transport in rat adipose cells: modulation of transporter activity by isoproterenol and adenosine. J Biol Chem 261:10033-10036, 1986
34. Young DA, Wallberg-Henriksson H, Cranshaw J, Chen M, Holloszy JO: Effect of catecholamines on glucose uptake and glycogenolysis in rat skeletal muscle. Am J Physiol 248:C406-C409, 1985
35. Wasserman DH, Lickley HL, Vranic M: Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes. J Appl Physiol 59:1282-1289, 1985
36. Dimitrakoudis D, Ramlal T, Rastogi S, Vranic M, Klip A: Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. Biochem J 284:341-348, 1992
37. Mathoo JM, Shi ZQ, Klip A, Vranic M: Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle. Diabetes 48:1281-1288, 1999
38. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
39. James DE, Burleigh KM, Kraegen EW: In vivo glucose metabolism in individual tissues of the rat: interaction between epinephrine and insulin. J Biol Chem 261:6366-6374, 1986
40. Spraul M, Ravussin E, Baron AD: Lack of relationship between muscle sympathetic nerve activity and skeletal muscle vasodilation in response to insulin infusion. Diabetologia 39:91-96, 1996
41. Sigal RJ, Fisher SJ, Halter JB, Vranic M, Marliss EB: Glucoregulation during and after intense exercise: effects of beta-adrenergic blockade in subjects with type 1 diabetes mellitus. J Clin Endocrinol Metab 84:3961-3971, 1999
42. Simonson DC, Koivisto V, Sherwin RS, Ferrannini E, Hendler R, Juhlin-Dannfelt A, DeFronzo RA: Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics. J Clin Invest 73:1648-1658, 1984
43. Purdon C, Brousson M, Nyveen SL, Miles PD, Halter JB, Vranic M, Marliss EB: The roles of insulin and catecholamines in the glucoregulatory response during intense exercise and early recovery in insulin-dependent diabetic and control subjects. J Clin Endocrinol Metab 76:566-573, 1993
44. Ziegler MG, Chernow B, Woodson LC, Coyle J, Cruess D, Lake CR: The effect of propranolol on catecholamine clearance. Clin Pharmacol Ther 40:116-119, 1986
45. Buczek-Thomas JA, Jaspers SR, Miller TB Jr: Adrenergic activation of glycogen phosphorylase in primary culture diabetic cardiomyocytes. Am J Physiol 262:H649-H653, 1992
46. Buczek-Thomas JA, Jaspers SR, Miller TB Jr: Post-receptor defect accounts for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes. Mol Cell Biochem 117:63-70, 1992
47. Ramlal T, Rastogi S, Vranic M, Klip A: Decrease in glucose transporter number in skeletal muscle of mildly diabetic (streptozotocin-treated) rats. Endocrinology 125:890-897, 1989
48. Bolinder J, Sjoberg S, Arner P: Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM. Diabetologia 39:845-853, 1996
49. Stevenson RW, Steiner KE, Connolly CC, Fuchs H, Alberti KG, Williams PE, Cherrington AD: Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol 260:E363-E370, 1991
50. Signal R, Purdon C, Fisher S, Halter JB, Vranic M, Marliss EB: Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects. J Clin Endocrinol Metab 79:1049-1057, 1994
51. Klip A, Ramlal T, Young DA, Holloszy JO: Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 224:224-230, 1987
52. Cushman SW, Warzala LJ: Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell: apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 255:4758-4762, 1980
53. Sternlicht E, Barnard RJ, Grimditch GK: Mechanism of insulin action on glucose transport in rat skeletal muscle. Am J Physiol 254:E633-E638, 1988
54. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219-225, 1981
55. Tack CJ, Lenders JW, Willemsen JJ, van Druten JA, Thien T, Lutterman JA, Smits P: Insulin stimulates epinephrine release under euglycemic conditions in humans. Metabolism 47:243-249, 1998
56. Paramore DS, Fanelli CG, Shah SD, Cryer PE: Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia. Am J Physiol 275:E872-E881, 1998